Diverse Possibilities of Si-Based Agent, a Unique New Antioxidant
Antioxidants · 08.05.2023 · 12 (5) · 1061
DOI: 10.3390/antiox12051061 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Antioxidants, online erschienen am 08.05.2023. Verfasst von Yoshihisa Koyama und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neuroscience and Cell Biology, Osaka University Graduate School of Medicine, Suita 565-0871, Japan. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science., Japan Science and Technology Agency, Nobelpharma Co., Ltd..
Abstract (Originalsprache)
Antioxidant therapy is an effective approach for treating diseases in which oxidative stress is involved in the onset of symptoms. This approach aims to rapidly replenish the antioxidant substances in the body when they are depleted due to excess oxidative stress. Importantly, a supplemented antioxidant must specifically eliminate harmful reactive oxygen species (ROS) without reacting with physiologically beneficial ROS, which are important to the body. In this regard, typically used antioxidant therapies can be effective, but may cause adverse effects due to their lack of specificity. We believe that Si-based agents are epoch-making drugs that can overcome these problems associated with current antioxidative therapy. These agents alleviate the symptoms of oxidative-stress-associated diseases by generating large amounts of the antioxidant hydrogen in the body. Moreover, Si-based agents are expected to be highly effective therapeutic drug candidates because they have anti-inflammatory, anti-apoptotic, and antioxidant effects. In this review, we discuss Si-based agents and their potential future applications in antioxidant therapy. There have been several reports of hydrogen generation from silicon nanoparticles, but unfortunately, none have been approved as pharmaceutical agents. Therefore, we believe that our research into medical applications using Si-based agents is a breakthrough in this research field. The knowledge obtained thus far from animal models of pathology may greatly contribute to the improvement of existing treatment methods and the development of new treatment methods. We hope that this review will further revitalize the research field of antioxidants and lead to the commercialization of Si-based agents.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neuroscience and Cell Biology, Osaka University Graduate School of Medicine, Suita 565-0871, Japan.
- Addiction Research Unit, Osaka Psychiatric Research Center, Osaka Psychiatric Medical Center, Osaka 541-8567, Japan.
- SANKEN, Osaka University, Suita 567-0047, Japan.
ORCID-Profile: Yoshihisa Koyama
Förderung
- Japan Society for the Promotion of Science.
- Japan Science and Technology Agency
- Nobelpharma Co., Ltd.
- JSPS KAKENHI
- Center of Innovation Program (COI Program)
- JST Japan and Osaka-University-Nobelpharma collaborative R&D program
Zitieren
APA
Koyama, Y., Kobayashi, Y., Kobayashi, H., & Shimada, S. (2023). Diverse Possibilities of Si-Based Agent, a Unique New Antioxidant. Antioxidants, 12(5), 1061. https://doi.org/10.3390/antiox12051061
Vancouver
Koyama Y, Kobayashi Y, Kobayashi H, Shimada S. Diverse Possibilities of Si-Based Agent, a Unique New Antioxidant. Antioxidants. 2023;12(5):1061. doi:10.3390/antiox12051061
BibTeX
@article{Koyama2023,
author = {Koyama, Yoshihisa and Kobayashi, Yuki and Kobayashi, Hikaru and Shimada, Shoichi},
title = {Diverse Possibilities of Si-Based Agent, a Unique New Antioxidant},
journal = {Antioxidants},
year = {2023},
volume = {12},
number = {5},
pages = {1061},
doi = {10.3390/antiox12051061}
}
EUVIMED